Erasca, INC.(ERAS)
盘后8.21-0.10-1.17%17:20 EST
8.31+0.81+10.73%
行情数据延迟15分钟
- 最新
- 推荐
暂无内容公司概况
公司名称Erasca, INC.所属市场NASDAQ成立日期- -员工人数- -办公地址- -邮政编码- -联系电话- -联系传真- -公司概况Erasca, Inc.于2018年7月2日在特拉华州注册成立。该公司是一家临床阶段的精准肿瘤学公司，专注于发现、开发和商业化RAS/MAPK通路驱动癌症患者的疗法。该公司由精准肿瘤学和RAS靶向领域的领先先驱共同创立，旨在创造新的疗法和联合方案，旨在全面关闭RAS/MAPK通路以治疗癌症。- 01-12 13:00Form 8-K - Current report重要事件披露Form 8-K - Current report
- 01-07Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-12-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-17Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-11-13Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-11-13Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-10-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-09-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-21Form CORRESP - CorrespondenceSEC问询函Form CORRESP - Correspondence
- 2025-08-15Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-08-12Form 10-Q - Quarterly report [Sections 13 or 15(d)]季度报告Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-08-12Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-07-16Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 2025-06-26Form 8-K - Current report重要事件披露Form 8-K - Current report
- 2025-06-16Form 144 - Report of proposed sale of securities关联方拟减持公告Form 144 - Report of proposed sale of securities
- 分时
- 5日
- 日
- 周
- 月
数据加载中...
最高
8.45
今开
7.52
量比
0.64
最低
7.52
昨收
7.51
换手率
6.74%